As of 2026-10-07, the EV/EBITDA ratio of NGM Biopharmaceuticals Inc (NGM) is -0.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NGM's latest enterprise value is 72.71 mil USD. NGM's TTM EBITDA according to its financial statements is -149.48 mil USD. Dividing these 2 quantities gives us the above NGM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.8x - 8.0x | 6.8x |
| Forward P/E multiples | 6.7x - 9.7x | 7.6x |
| Fair Price | (11.26) - (13.73) | (12.23) |
| Upside | -831.2% - -991.7% | -894.0% |
| Date | EV/EBITDA |